GGrantIndex
Sort

40,608 grants matching prostate cancer

Validation of Biomarkers of Risk for the Early Detection of Lung Cancer

$632,571
Pierre P Massion · Vanderbilt University · U01 · FY2010 · CA

Targeting B7-H3 in ovarian cancer

$632,310
Gianpietro Dotti · Univ Of North Carolina Chapel Hill · R01 · FY2021 · CA

Genetic Susceptibility And The Environment In Cancer Risk

$632,196
Jack A Taylor · National Institute Of Environmental Health Sciences · ZIA · FY2015 · ES

Improving Prostate Cancer Outcome Prediction Through Noninvasive exRNA Assessment

$632,140
Matthew R Cooperberg · University Of California, San Francisco · R01 · FY2018 · CA

Macro-vasculature: A Novel Image Biomarker of Lung Cance

$632,139
Jiantao Pu · University Of Pittsburgh At Pittsburgh · R01 · FY2022 · CA

Development of Spectral Phase Contrast Micro-CT

$632,061
Mini Das · University Of Houston · R01 · FY2020 · EB

Alpha-Particle Emitter Radiopharmaceutical Therapy for Liver Cancer

$632,025
Jessie Nedrow · Johns Hopkins University · R01 · FY2020 · CA

Prostate Cancer Radio-Pathomics for Differentiating Clinically Significant Disease

$631,957
Peter S Laviolette · Medical College Of Wisconsin · R01 · FY2021 · CA

A transdisciplinary approach for dissecting stem cell states in prostate cancer

$631,956
Raul Rabadan · Columbia University Health Sciences · U01 · FY2025 · CA

Exploring PSMA Biology in Tumor neovasculature

$631,933
Jan Grimm · Sloan-Kettering Inst Can Research · R01 · FY2017 · CA

Effects of Androgen Deprivation Therapy on Preclinical Symptoms of Alzheimer's Disease

$631,855
Matthew S Panizzon · University Of California, San Diego · R01 · FY2021 · AG

Improving Patient-Important Outcomes with Testosterone Replacement in Hypogonadal Men with a Prior History of Cancer

$631,770
Jose M. Garcia · Seattle Inst For Biomedical/Clinical Res · R01 · FY2024 · CA

Improved Detection of Prostate Cancer with Nanoparticle-based Ultrasound Contrast Agents Targeted to PSMA

$631,743
Agata A Exner · Case Western Reserve University · R01 · FY2021 · EB

DBM Anti-Proliferative Lead Small Molecules for Polycystic Kidney Disease

$631,732
Erik Mills Schwiebert · Discoverybiomed, Inc. · R44 · FY2015 · DK

Translational Pathology Core

$631,729
Peter A Jones · University Of Southern California · P30 · FY2014 · CA

Understanding and addressing rejection of personalized cancer risk information

$631,686
Laura D. Scherer · University Of Colorado Denver · R01 · FY2025 · CA

Mouse Cancer Models for Integrated Tissue/Serum Proteomics and Molecular Imaging

$631,555
Sanjiv S Gambhir · Stanford University · U54 · FY2008 · CA

Multi-Site Development & Evaluation of a Quantitative 3D Hyperpolarized C-13 MRI Clinical Prostate Cancer Exam

$631,537
James A Bankson · University Of Tx Md Anderson Can Ctr · R01 · FY2019 · CA

PSMA-targeted AuNPs for MR guided radiotherapy and radiosensitization

$631,513
James Peter Basilion · Case Western Reserve University · R01 · FY2024 · CA

Multiethnic GWAS and TWAS to Inform Risk Prediction for Prostate Cancer

$631,506
Christopher Alan Haiman · University Of Southern California · U01 · FY2023 · CA

African American Families Fighting Parental Cancer Together

$631,490
Adam Davey · University Of Delaware · R01 · FY2021 · CA

Identifying Ovarian Cancer Susceptibility Alleles using Genome-Wide Scan Data

$631,470
Celeste Leigh Pearce · University Of Southern California · R01 · FY2011 · CA

Early Detection and Diagnosis of Lung Cancer with Endomicroscopy

$631,410
Melissa J Suter · Massachusetts General Hospital · R01 · FY2025 · CA

Targeting the Plk1/Pdcd4/mTORC2 Signaling to Treat Castration-Resistant Prostate Cancer

$631,310
Xiaoqi Liu · University Of Kentucky · R01 · FY2025 · CA

Annotating Oncogene Status in Prostate Cancer with Zr-89-transferrin PET

$631,257
Jason S Lewis · Sloan-Kettering Inst Can Research · R01 · FY2016 · CA